August 14, 2015
A New York federal judge on Friday ruled that Actavis Inc. and other drug manufacturers infringed most of the claims of Endo Pharmaceuticals Inc.'s patents related to the painkiller Opana ER, ordering Actavis to pull its generic version from the market and blocking any other proposed generics from launching.